| Literature DB >> 30565652 |
Alejandro Roisman1,2, Giancarlo Castellano3, Alba Navarro1,4, Blanca Gonzalez-Farre1,5, Patricia Pérez-Galan1, Anna Esteve-Codina6,7, Marc Dabad6,7, Simon Heath6,7, Marta Gut6,7, Mattia Bosio8, Pau Bellot9, Philippe Salembier9, Albert Oliveras9, Irma Slavutsky2, Laura Magnano10, Heike Horn11, Andreas Rosenwald12, German Ott13, Marta Aymerich14, Armando López-Guillermo10, Pedro Jares1,5, José I Martín-Subero1,4, Elías Campo1,4,14, Luis Hernández1,4.
Abstract
Long non-coding RNAs (lncRNAs) comprise a family of non-coding transcripts that are emerging as relevant gene expression regulators of different processes, including tumour development. To determine the possible contribution of lncRNA to the pathogenesis of follicular lymphoma (FL) we performed RNA-sequencing at high depth sequencing in primary FL samples ranging from grade 1-3A to aggressive grade 3B variants using unpurified (n = 16) and purified (n = 12) tumour cell suspensions from nodal samples. FL grade 3B had a significantly higher number of differentially expressed lncRNAs (dif-lncRNAs) with potential target coding genes related to cell cycle regulation. Nine out of the 18 selected dif-lncRNAs were validated by quantitative real time polymerase chain reaction in an independent series (n = 43) of FL. RP4-694A7.2 was identified as the top deregulated lncRNA potentially involved in cell proliferation. RP4-694A7.2 silencing in the WSU-FSCCL FL cell line reduced cell proliferation due to a block in the G1/S phase. The relationship between RP4-694A7.2 and proliferation was confirmed in primary samples as its expression levels positively related to the Ki-67 proliferation index. In summary, lncRNAs are differentially expressed across the clinico-biological spectrum of FL and a subset of them, related to cell cycle, may participate in cell proliferation regulation in these tumours.Entities:
Keywords: LncRNA; RNA-seq; cell proliferation; follicular lymphoma
Mesh:
Substances:
Year: 2018 PMID: 30565652 DOI: 10.1111/bjh.15656
Source DB: PubMed Journal: Br J Haematol ISSN: 0007-1048 Impact factor: 6.998